• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ:IRON)

78.93 +22.09 (+38.86%)
Delayed Quote Updated: 4:00 PM EDT, Oct 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,477,709
Open 72.70
Bid (Size) 77.58 (100)
Ask (Size) 77.97 (300)
Prev. Close 56.84
Today's Range 69.98 - 80.22
52wk Range 40.00 - 99.50
Shares Outstanding 22,877,552
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Disc Medicine Announces Proposed $350 Million Public Offering of Common Stock and Pre-Funded Warrants
Today 16:01 EDT
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine’s Bitopertin Nails Phase III Endpoints, Eyes FDA Resubmission ↗
Today 12:02 EDT
Disc Medicine (NASDAQ:IRON) said its Phase III APOLLO trial of investigational bitopertin met both co-primary endpoints and all secondary endpoints in patients with erythropoietic protoporphyria (EPP)... 
Via MarketBeat

Performance

52-Week Range 20.7% below 52-week high
78.93
40.0052W Low 99.5052W High
1 Week
55.001W Low 62.761W High

Disc Medicine, Inc. - Common Stock (IRON) traded between $40.00 and $99.50 over the past 52 weeks and last traded at $78.93, 20.7% below its 52-week high. Over the past week it ranged between $55.00 and $62.76.

Past 12 Months
+30.5%
+13.5%
+6.1%
+10.5%
-0.2%
-9.5%
1W +$18.45
1M +$9.40
3M +$4.55
6M +$7.52
YTD -$0.16
1Y -$8.24

IRON was -9.5% over the past year, +10.5% over six months, -0.2% year to date, +30.5% in the last week.

12 Months vs Market
IRON
-9.5%
DIA
+11.1%
SPY
+14.2%
QQQ
+17.5%
IWM
+9.3%

Over the past 12 months IRON returned -9.5% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.

Volume & Liquidity 17.16× 3-mo avg
Today 8,477,709 3-mo avg 494.0K
1W
592.0K
1M
652.0K
3M
494.0K
6M
532.9K
YTD
576.6K
1Y
582.5K

IRON most recently traded 8,477,709 shares against a 3-month average daily volume of 494.0K.

More News

Read More
Premarket Movers Oct. 19: Disc Medicine Jumps 51.62%, Rubico Falls 33.84% ↗
Today 8:30 EDT
Via Chartmill
News headline image
Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)
Today 7:00 EDT
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
October 18, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
October 05, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Presents Initial Results from RESTORE-PV Phase 2 Trial in Patients with Polycythemia Vera (PV) at the 14th Society of Hematologic Oncology (SOHO) Annual Meeting
September 09, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
September 02, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting
August 31, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
August 14, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 15, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
June 12, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
June 09, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 05, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
June 01, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges ↗
May 26, 2026
Via MarketBeat
News headline image
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
May 12, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
May 11, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 07, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
May 05, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 28, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
April 25, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 21, 2026
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?
Yes, Disc Medicine, Inc. - Common Stock is publicly traded.
What exchange does Disc Medicine, Inc. - Common Stock trade on?
Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Disc Medicine, Inc. - Common Stock?
The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market
What is the current price of Disc Medicine, Inc. - Common Stock?
The current price of Disc Medicine, Inc. - Common Stock is 78.93
When was Disc Medicine, Inc. - Common Stock last traded?
The last trade of Disc Medicine, Inc. - Common Stock was at 10/19/26 04:00 PM ET
What is the market capitalization of Disc Medicine, Inc. - Common Stock?
The market capitalization of Disc Medicine, Inc. - Common Stock is 1.81B
How many shares of Disc Medicine, Inc. - Common Stock are outstanding?
Disc Medicine, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap